Related Experiment Video
Updated: May 11, 2026
05:19
Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
Published on: March 29, 2019
DNA methylation-based biomarkers in bladder cancer
Raju Kandimalla1, Angela A van Tilborg, Ellen C Zwarthoff
1Department of Pathology, Erasmus MC, P. O. Box 2040, 3000 CA Rotterdam, The Netherlands.
Nature Reviews. Urology
|May 1, 2013
Summary
DNA methylation patterns differ in bladder cancer, distinguishing subtypes and offering potential biomarkers. Further research is needed to validate these methylated genes for improved diagnosis and patient treatment strategies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Urinary bladder cancer is a prevalent malignancy in Western countries.
- DNA methylation plays a significant role in bladder cancer pathogenesis.
- Distinct methylation patterns exist between non-muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC), and between FGFR3-mutant and wild-type tumors.
Purpose of the Study:
- To explore the potential of methylated genes as diagnostic and prognostic biomarkers for bladder cancer.
- To highlight the need for further validation of identified methylated genes for clinical application.
Main Methods:
- Analysis of DNA methylation patterns in bladder cancer.
- Identification of distinct methylation profiles between different bladder cancer subtypes and molecular groups.
- Review of existing studies linking methylated genes to patient survival.
Main Results:
- Specific methylation patterns are associated with bladder cancer subtypes (NMIBC vs. MIBC) and FGFR3 mutation status.
- Several methylated genes (e.g., CDH1, FHIT, RASSF1A) are linked to poor survival in muscle-invasive bladder cancer patients.
Conclusions:
- Methylated genes show promise as biomarkers for bladder cancer diagnosis, prognosis, and surveillance.
- Validation of these markers is crucial for advancing clinical decision-making and personalized treatment strategies for bladder cancer patients.
